Hims and Hers Health, Inc. (NYSE: HIMS) trended on Wednesday after the company outlined an expanded weight-management push tied to
Raul Shah from DocShah Financial shares his bullishness on top holdings, Hims & Hers (HIMS), UnitedHealth (UNH), and Gambling.com (GAMB). Tax gain harvesting and more tax takeaways for investors.
Hims & Hers expands its digital care platform with labs tracking, multi-cancer screening access and broader treatments as it scales personalized healthcare globally.
Hims and Hers Health Inc (NYSE: HIMS) shares are pulling back Monday morning, giving back a portion of last week's sharp rally.
The drama and uncertainty around Novo Nordisk and Hims and Hers Health might finally be ending.
Hims and Hers Health (NYSE: HIMS - Get Free Report) and SOPHiA GENETICS (NASDAQ: SOPH - Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies ba
Retail investors talked up five hot stocks this week (March 9 to March 13) on X and Reddit's r/WallStreetBets, driven by retail hype, earnings, AI buzz, and corporate news flow.
Nine of the portfolio's 10 equity sectors made a positive impact on performance, with Health Care, Industrials, and Materials making the largest positive contributions. Palvella's shares appreciated s
Hims & Hers Health, Inc. (HIMS) closed at $23.84 in the latest trading session, marking a -7.88% move from the prior day.
Expand NYSE: HIMS Hims & Hers Health Today's Change (-7.75%) $-2.00 Current Price $23.88 Key Data Points Market Cap $5.9B Day's Range $23.77 - $27.20 52wk Range $13.74 - $70.43 Volume 2.1M Avg Vol 30M
HIMS is navigating margin and regulatory pressure, but new benefits, a Novo Nordisk tie-up and platform growth could drive its next move.
Shares of Eli Lilly and Company (LLY) slipped about 1% in early Thursday trading after the drugmaker cautioned about potential safety concerns tied to compounde
Hims & Hers Health ( NYSE:HIMS ) looked like a fallen growth star earlier this year.
Hims & Hers Health (HIMS) is rated a Speculative Buy after its renewed partnership with Novo Nordisk, providing legitimate access to lucrative branded GLP-1 therapies. HIMS has demonstrated rapid reve

Does This Deal Make Novo Nordisk Stock a Buy?

10:15am, Thursday, 12'th Mar 2026
Not many things have gone right for Novo Nordisk recently, but this is one of them.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE